The highly productive, specialized researchers within the Weill Cornell Department of Genetic Medicine are leaders in their respective fields. Our gene therapy and stem cell researchers have carried out human trials for cystic fibrosis, cardiac ischemia, cancer and central nervous system disorders, and were the first to use a recombinant virus as a vehicle for in vivo gene therapy. In addition, our personalized medicine researchers utilize state-of-the-art microarray technology for genome-wide characterization of gene expression, single nucleotide polymorphism and copy number variation, conducting cutting-edge studies to identify candidate genes associated with complex conditions including chronic obstructive pulmonary disease.
